85599-21-9

Upstream product

• 578-57-4 2-bromoanisole 
• 28240-69-9 1,2-bis(dichlorophosphino)ethane 
• 85599-16-2 1,2-Ethanediylbis 
• 71360-04-8 Bisphosphine oxide 

Downstream Products

• 340698-59-1 [Ni(1,2-bis(di(o-methoxyphenyl)phosphino)ethane)Cl₂] 
• 340698-68-2 [Ni(1,2-bis(di(o-methoxyphenyl)phosphino)ethane)I₂] 
• 340698-62-6 [Ni(1,2-bis(di(o-methoxyphenyl)phosphino)ethane)Br₂] 
• 452083-81-7 chloro(η5-cyclopentadienyl)(1,2-bis-(di(o-methoxyphenyl)phosphino)ethane)ruthenium(II) 
• 1004323-43-6 chloro(1,2-bis(di(2-methoxyphenyl)phosphino)ethane)methylpalaldium(II) 
• 1004323-38-9 dichloro(1,2-bis(di(2-methoxyphenyl)phosphino)ethane)palaldium(II) 

Relevant academic research and scientific papers

Ethylene oligomerization catalyst systems having enhanced selectivity

Disclosed herein is a catalyst system for selective oligomerization of ethylene, which comprises a P—C—C—P frame-work ligand, which is (R1)(R2)P—(R5)CHCH(R6)—P(R3)(R4), and a chromium-based metal compound. Also disclosed is a method of greatly enhancing the activity and selectivity of oligomerization, such as trimerization or tetramerization, using a ligand having a specific steric arrangement structure.

Antitumor activity of bis(diphenylphosphino)alkanes, their gold(i) coordination complexes, and related compounds

Bisphosphines related to bis(diphenylphosphino)ethane (dppe) and their gold complexes are described that are active in a spectrum of transplantable tumor models. When administered ip on days 1-5 at its maximally tolerated dose (MTD) of 40 μmol/kg, dppe re